ATE244241T1 - Hemmung der menschlichen telomerase durch g- quadruplex interaktionverbindung - Google Patents

Hemmung der menschlichen telomerase durch g- quadruplex interaktionverbindung

Info

Publication number
ATE244241T1
ATE244241T1 AT99904571T AT99904571T ATE244241T1 AT E244241 T1 ATE244241 T1 AT E244241T1 AT 99904571 T AT99904571 T AT 99904571T AT 99904571 T AT99904571 T AT 99904571T AT E244241 T1 ATE244241 T1 AT E244241T1
Authority
AT
Austria
Prior art keywords
telomerase
inhibition
quadruplex
human telomerase
human
Prior art date
Application number
AT99904571T
Other languages
English (en)
Inventor
Sean M Kerwin
Oleg Y Fedoroff
Miguel Salazar
Laurence H Hurley
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE244241T1 publication Critical patent/ATE244241T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99904571T 1998-02-04 1999-02-04 Hemmung der menschlichen telomerase durch g- quadruplex interaktionverbindung ATE244241T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7362998P 1998-02-04 1998-02-04
PCT/US1999/002353 WO1999040087A2 (en) 1998-02-04 1999-02-04 Inhibition of human telomerase by a g-quadruplex-interaction compound

Publications (1)

Publication Number Publication Date
ATE244241T1 true ATE244241T1 (de) 2003-07-15

Family

ID=22114844

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99904571T ATE244241T1 (de) 1998-02-04 1999-02-04 Hemmung der menschlichen telomerase durch g- quadruplex interaktionverbindung

Country Status (6)

Country Link
US (4) US6156763A (de)
EP (1) EP1053237B1 (de)
AT (1) ATE244241T1 (de)
AU (1) AU2494799A (de)
DE (1) DE69909246D1 (de)
WO (1) WO1999040087A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156763A (en) * 1998-02-04 2000-12-05 Board Of Regents, The University Of Texas System Inhibition of human telomerase by a g-quadruplex-interaction compound
SK7402002A3 (en) * 1999-11-29 2002-11-06 Aventis Pharma Sa Arylamine derivatives and their use as anti-telomerase agent
FR2801588B1 (fr) * 1999-11-29 2002-03-01 Aventis Pharma Sa Derives chimiques et leur application comme agent antitelomerase
WO2002012194A1 (fr) * 2000-08-08 2002-02-14 Aventis Pharma S.A. Derives de phenanthridine et leur application comme agents antitelomerases
FR2821355A1 (fr) * 2001-02-23 2002-08-30 Aventis Pharma Sa Derives chimiques et leur application comme agent antitelomerase
US6887873B2 (en) 2001-03-23 2005-05-03 Aventis Pharma S.A. Triazine derivatives and their application as antitelomerase agents
US6753411B2 (en) 2001-03-26 2004-06-22 The Regents Of The University Of Colorado Protection-of-telomere-1 (POT-1) proteins
WO2002096903A2 (fr) * 2001-05-28 2002-12-05 Aventis Pharma S.A. Derives chimiques et leur application comme agent antitelomerase
EP1519725A4 (de) * 2002-04-05 2005-08-10 Cyternex Inc Verfahren zum targeting von quadruplex-dna
WO2004019283A2 (en) * 2002-08-20 2004-03-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for regulating transcription by targeting quadruplex dna
CA2800237C (en) * 2002-12-19 2016-05-17 The Scripps Research Institute Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
US7781163B2 (en) 2003-01-08 2010-08-24 Lesley Davenport G-quadruplex binding assays and compounds therefor
US20050113324A1 (en) * 2003-01-15 2005-05-26 Bondarev Igor E. Modulation of line-1 reverse transcriptase
US20040180345A1 (en) * 2003-03-14 2004-09-16 Ingeneus Corporation Pre-incubation method to improve signal/noise ratio of nucleic acid assays
EP1673478A4 (de) * 2003-10-14 2007-08-22 Cylene Pharmaceuticals Inc Kompetitionsassay zur identifizierung von modulatoren von quadruplex-nukleinsäuren
US6979738B2 (en) * 2003-10-22 2005-12-27 Academia Sinica Quadruplex stabilizer
US20050249669A1 (en) * 2003-10-22 2005-11-10 Academia Sinica Quadruplex stabilizer
US7691624B2 (en) * 2003-10-22 2010-04-06 Academia Sinica Cancer cell detecting devices
WO2005049867A1 (en) * 2003-11-17 2005-06-02 Cylene Pharmaceuticals, Inc. Methods for identifying modulators of quadruplex nucleic acids
WO2005089094A2 (en) * 2003-11-21 2005-09-29 The Board Of Regents Of The University And Community College System Of Nevada Materials and methods for the preparation of anisotropically-ordered solids
WO2005113523A1 (en) * 2004-05-20 2005-12-01 Foldrx Pharmaceuticals, Inc. 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
US20080119492A1 (en) * 2005-07-29 2008-05-22 Jean-Marie Lehn Compositions and methods for treating cancer and other diseases characterized by abnormal cell proliferation
US20100249175A1 (en) * 2005-12-02 2010-09-30 Wilson W David Dicationic compounds which selectively recognize G-quadruplex DNA
KR100833492B1 (ko) * 2005-12-08 2008-05-29 한국전자통신연구원 핵산 나노구조체 및 그의 제조 방법
WO2007137000A2 (en) * 2006-05-16 2007-11-29 The Arizona Board Of Regents On Behalf Of The University Of Arizona Combination cancer chemotherapy
WO2008034016A2 (en) * 2006-09-15 2008-03-20 Foldrx Pharmaceuticals, Inc. Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
ITRM20070209A1 (it) * 2007-04-12 2008-10-13 Univ Roma Derivati coronenici idrosolubili attivi come inibitori della telomerasi umana mediante induzione di strutture g-quadruplex e loro uso come agenti antitumorali.
WO2009051796A2 (en) * 2007-10-17 2009-04-23 The University Of North Carolina At Chapel Hill 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents
JP2011500087A (ja) * 2007-10-22 2011-01-06 ザ ウィスター インスティテュート テロメラーゼ活性を調節する化合物の同定方法
US8377992B2 (en) 2007-10-22 2013-02-19 The Wistar Institute TRBD-binding effectors and methods for using the same to modulate telomerase activity
EP3029154B1 (de) * 2008-10-17 2017-10-04 Geron Corporation Verfahren zur messung der ansprechempfindlichkeit eines patienten auf eine telomerasehemmtherapie
RU2586330C2 (ru) 2011-09-16 2016-06-10 Пфайзер Инк. Твердые формы ингибитора диссоциации транстиретина
CN103910727B (zh) * 2012-12-31 2016-06-15 北京大学 STAT3-Hif1α信号通路抑制剂及其在抗肿瘤中的应用
CN103497154A (zh) * 2013-08-12 2014-01-08 北京化工大学 一种水溶性苝酰亚胺类化合物及其作为dna嵌插剂和在抑制癌细胞生长中的应用
US11022592B2 (en) * 2015-12-02 2021-06-01 University Of Utah Research Foundation Chemical self-doping of one-dimensional organic nanomaterials for high conductivity application in chemiresistive sensing gas or vapor
CN105842287B (zh) * 2016-03-16 2019-01-01 济南市农业科学研究院 用于检测二氧化氮的纳米材料及气敏传感器元件
CN110237076A (zh) * 2019-07-29 2019-09-17 河南大学 PDINCl在制备抗肿瘤药物中的应用
US20210333284A1 (en) * 2020-04-28 2021-10-28 Purdue Research Foundation Methods and materials for large-scale assessment of ligand binding selectivity of g-quadruplex recognition using custom g4 microarrays
CN112521388B (zh) * 2020-12-30 2021-11-09 河南大学 一种苝酰亚胺衍生物及应用
CN112724137B (zh) * 2021-01-19 2021-10-26 河南大学 一种苝酰亚胺衍生物及其制备方法和应用
CN116925074B (zh) * 2023-07-28 2025-08-15 河南大学 一种苝酰亚胺衍生物pdic-dpc及应用
CN118108720B (zh) * 2023-12-28 2026-03-10 河南大学 一种苝酰亚胺衍生物pdic-ns及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD299733A7 (de) * 1980-12-23 1992-05-07 Bitterfeld Chemie Verfahren zur herstellung von schwarzen tarnpigmenten
JP3362865B2 (ja) * 1991-03-21 2003-01-07 クラリアント・ゲゼルシヤフト・ミト・ベシユレンクテル・ハフツング ペリレン化合物の分子内塩、その製造方法およびその用途
DE4225357A1 (de) * 1992-07-31 1994-02-03 Basf Ag Glanzpigmente auf Basis mit extern basischen, organischen Farbmitteln beschichteter, plättchenförmiger Substrate
US5416089A (en) * 1993-06-24 1995-05-16 The Du Pont Merck Pharmaceutical Company Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
US5672643A (en) * 1995-09-29 1997-09-30 Minnesota Mining And Manufacturing Company Fluorescent dye blends
US5920429A (en) * 1995-09-29 1999-07-06 Minnesota Mining And Manufacturing Company Fluorescent dye blends
EP0988037A1 (de) * 1997-02-05 2000-03-29 Board Of Regents, The University Of Texas System Porphyrinverbindungen als telomerase inhibitoren
US6166210A (en) * 1997-12-15 2000-12-26 Ciba Specialty Chemicals Corporation Perylene imide monocarboxylic acids
US6156763A (en) * 1998-02-04 2000-12-05 Board Of Regents, The University Of Texas System Inhibition of human telomerase by a g-quadruplex-interaction compound
AU2657499A (en) * 1998-02-04 1999-08-23 Board Of Regents, The University Of Texas System Synthesis of quinobenzoxazine analogues with topoisomerase ii and quadruplex interactions for use as antineoplastic agents
US6492117B1 (en) * 2000-07-12 2002-12-10 Gendaq Limited Zinc finger polypeptides capable of binding DNA quadruplexes

Also Published As

Publication number Publication date
US6689887B2 (en) 2004-02-10
US6156763A (en) 2000-12-05
WO1999040087A2 (en) 1999-08-12
AU2494799A (en) 1999-08-23
WO1999040087A3 (en) 1999-11-11
US20030040525A1 (en) 2003-02-27
US20020107258A1 (en) 2002-08-08
EP1053237A2 (de) 2000-11-22
EP1053237B1 (de) 2003-07-02
US20040229894A1 (en) 2004-11-18
DE69909246D1 (de) 2003-08-07
US6623930B2 (en) 2003-09-23

Similar Documents

Publication Publication Date Title
ATE244241T1 (de) Hemmung der menschlichen telomerase durch g- quadruplex interaktionverbindung
NZ524559A (en) 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
HRP20080664A2 (hr) Supstituirani piridinski herbicidi
SI1070056T1 (en) Phthalazinone pde iii/iv inhibitors
DK0931788T3 (da) Metalloproteasehæmmere
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
MY133969A (en) Indoloquinazolinones
ATE354622T1 (de) Flüssigkristallines medium
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
ATE299505T1 (de) Fungizide 6-(2-halo-4-alkoxyphenyl)- triazolopyrimidine
SE9903290D0 (sv) Novel compounds
EA200300378A1 (ru) Твердые амфотерные поверхностно-активные вещества
TR199901017A2 (xx) B�cek ilac� terkibi.
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
SI1377574T1 (de)
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
DK1204659T3 (da) Serotonerge benzofuraner
NZ336091A (en) Aqueous disinfecting cleaning composition
ATE286887T1 (de) Antibakterielle mittel
AU2001282238A1 (en) Dihydroporphyrin derivatives and their uses
DE602004014523D1 (de) Imidazoä4,5-büpyridinderivate als inhibitoren der induzierbaren no-synthase
AU2003297077A1 (en) Organic activator
ES2196798T3 (es) Derivados heterociclicos de carboxamida como inhibidores de la produccion de oxido nitrico.
DK1261325T3 (da) Tumorinhiberende sammensætninger, der indeholder nitroacridiner

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties